Mongolian National University of Medical Sciences   Report issue

Academic/Hospital Phase 1 Phase 3
Founded: Ulan Bator Mongolia (1942)

Organization Overview

First Clinical Trial
2019
NCT04126135
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Mongolian National University of Medical Sciences

Active Ingredients

Drugs in Phase 3 Trials (2)

cytisine (1 trial)

nicotine (nicorette) (1 trial)

Drugs in Phase 1 Trials (1)

interferon alpha-2b (Intron-A) (1 trial)

Drugs in Other Trials (1)

hyaluronic acid (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Behavior, Addictive (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 4